AscellaHealth Named National Association of Specialty Pharmacy (NASP) Strategic Channel Partner of the Year BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy solutions company, is extremely honored to be named Strategic Channel Partner of the Year at the recent National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo. This award is
International
Volume 2, Issue 22: Adam Brodsky, M.D., CardiacSense, Discusses Improving Outcomes Through Noninvasive, Long-Term Heart Monitoring Device
Dear Colleagues, According to a survey from the British Dental Association, an increasing number of dental patients in the UK are travelling to foreign countries to seek dental treatment. However, the association is urging dental care travelers to educate themselves on the risks and alternatives before deciding to receive treatment abroad. This
Spotlight Interview: Adam Brodsky, M.D., CardiacSense
About Adam M Brodsky, MD MM Adam M Brodsky, MD MM is an interventional cardiologist and medical advisor working with CardiacSense in Caesarea, Israel. He attended Medical School at Northwestern University Medical School in Chicago, IL, earning a combined MD MM degree at the medical school and the JL Kellogg Graduate
Industry News: Volume 2, Issue 22
Great Speech Develops Artificial Intelligence Platform to Refine Matching Process Between Patients and Most Qualified Speech Therapist HOLLYWOOD, Fla.--(BUSINESS WIRE)--Great Speech, a pioneer and leader in virtual speech therapy,today announces patient matching Artificial Intelligence (AI) technology to optimize pairing patients with the most qualified speech therapists in our network for
Volume 2, Issue 21: Michael Tu, Founder and CEO, Everyplace Labs Discusses Unique, Automated Self-Service Diagnostic Kiosk For Congregate Living Settings and Worksites
Dear Colleagues, The U.S. is a hot spot for medical tourists each year with patients often paying for expensive medical procedures out of their own pockets. However, the pandemic’s travel restrictions caused $1.9 billion of medical tourism revenue to be eliminated in 2020 and 2021, new research shows. This issue brings you
Spotlight Interview: Michael Tu, Founder and CEO, Everyplace Labs
Industry News: Volume 2, Issue 21
Virginia Lieutenant Governor Winsome Earle-Sears Joins Gala Celebration of Foot Levelers 70th Anniversary ROANOKE, Va.--(BUSINESS WIRE)--Foot Levelers, the world’s leading provider of hand-crafted custom, flexible orthotics serving multi-disciplinary professionals and clinicians, hosted a gala this week at their Roanoke, Virginia headquarters where Virginia's esteemed Lt. Governor Winsome Earle-Sears celebrated the Company’s
Volume 2, Issue 20: Sergio Fonda, President and Founder, and Matteo Confalonieri, CEO, IppocraTech, Discuss the Use of Non-Invasive Medical Device for the Simultaneous Measurement of the Five Vital Parameters
Dear Colleagues, I am excited to share my recent article titled, “Full Speed Ahead for International and US Domestic Medical Travel,” featured in the August issue of The Self Insurer! With the requirement for travelers to test negative for COVID-19 before entering the U.S. being lifted, the medical travel industry is
Spotlight Interview: Sergio Fonda, President and Founder, and Matteo Confalonieri, CEO, IppocraTech
About Sergio Fonda 2017 - presentVST - IppocraTechFounder, President and Working Partner in R&D 2011 – 2017University of Modena and Reggio EmiliaDepartment of Life SciencesAssociate Professor of BioengineeringResearch in the field of proteomics on possible therapies of ovarian cancer through data science methods;Research on objective methods of assessing cognitive stress through physiological
Industry News: Volume 2, Issue 20
INDUSTRY NEWS Full Speed Ahead for International and U.S. Domestic Medical Travel By Laura Carabello The Self Insurer – When the US Centers for Disease Control and Prevention lifted its requirement for travelers to test negative for COVID-19 before entering the US, the medical travel industry received another boost for program adoption. A post-COVID